EligibleTrials

Electrosurgical Bipolar Systems Versus Conventional Electrocautery After SLNBx

Recruiting · NCT06426810 · Interventional (participants receive a specific treatment) · Lead sponsor: SMG-SNU Boramae Medical Center

View the official record on ClinicalTrials.gov →
ObesityBipolar disorderBreast Cancer

Interventions studied

Electrosurgical bipolar system (LigaSure)

What this trial is about

The efficacy of electrosurgical bipolar systems in axillary lymph node dissection for breast cancer surgery is well known. In this study, the investigators aim to determine whether using electrosurgical bipolar systems helps reduce seroma formation in high-risk patients undergoing sentinel lymph node biopsy (SLNB) for breast cancer surgery. The investigators will focus on patients who are expected to experience high drainage output after SLNB, especially those who are obese (BMI\>25) or have undergone preoperative chemotherapy.

Who can take part

Age range
20 Years to 80 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.